Valuation: Manhattan Scientifics, Inc.

Market Cap 336K 295K 274K 252K 473K 32.32M 480K 3.25M 1.27M 15.89M 1.26M 1.23M 54.93M P/E 2022
-1.64x
P/E 2023 -1.25x
Enterprise Value 329K 289K 268K 246K 463K 31.64M 470K 3.19M 1.25M 15.56M 1.23M 1.21M 53.79M EV / Sales 2022
88,184,960x
EV / Sales 2023 -
Free-Float
100%
Yield 2022 *
-
Yield 2023 -
Current year 0
Extreme 0
0
1 year 0
Extreme 0
0
3 years 0
Extreme 0
0.01
5 years 0
Extreme 0
0.04
10 years 0
Extreme 0
0.06
Manager TitleAgeSince
Chief Executive Officer 74 2007-10-31
President 89 1997-12-31
Director TitleAgeSince
Chairman 89 -
Chairman 74 2007-10-31
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 559
0.00%+0.67%+35.24%+52.20% 601M
-1.37%+1.41%-0.35%-2.70% 368M
-1.49%-3.14%-27.21%-31.32% 82.71M
+0.49%+7.29%-28.97%-0.48% 50.36M
Average -0.47%+1.07%-5.32%+4.42% 220.37M
Weighted average by Cap. -0.55%+0.45%+15.72%+25.18%

Financials

2022 2023
Net sales 0.05 0.04 0.04 0.04 0.07 4.82 0.07 0.48 0.19 2.37 0.19 0.18 8.18 -
Net income -2.73M -2.4M -2.23M -2.05M -3.84M -263M -3.9M -26.48M -10.35M -129M -10.25M -10.03M -447M -1.16M -1.02M -952K -873K -1.64M -112M -1.67M -11.3M -4.41M -55.16M -4.37M -4.28M -191M
Net Debt -65K -57.09K -53.09K -48.72K -91.54K -6.26M -92.95K -630K -246K -3.08M -244K -239K -10.64M -7K -6.15K -5.72K -5.25K -9.86K -674K -10.01K -67.89K -26.53K -331K -26.28K -25.71K -1.15M
Logo Manhattan Scientifics, Inc.
Manhattan Scientifics, Inc. is focused on technology transfer and commercialization of these transformative technologies. The Company operates as a technology incubator. Its business model is to identify significant technologies; acquire them or the rights to them; secure the services of inventors, engineers or other staff who were instrumental in their creation; provide or contract for suitable work facilities, laboratories, and other aids where appropriate; prototype the technologies to demonstrate proof of principle feasibility; secure patent and or other intellectual property protection; secure early customers for product trials where feasible and appropriate; and commercialize through licenses, sales or cooperative efforts with other manufacturing and distribution firms. Its business model is based on licensing metals technology to metals manufacturers. Its technologies are in a development phase.
Employees
1
  1. Stock Market
  2. Stocks
  3. MHTX Stock